Pharma & Healthcare – the latest on CVS’s False Claims allegations, accusations of insularity haunt the Teva board and more.
CVS Caremark Pays $4.25 Million to Settle False Claims Allegations by Akin Gump Strauss Hauer & Feld LLP Published on jdsupra.com
Earlier this month, Caremark Incorporated – a drug benefit management company operated by drug retail giant CVS Caremark Corporation –agreed to pay $4.25 million to settle allegations that it knowingly failed to reimburse Medicaid, Tricare, and other governmental health care programs, for prescription drug costs paid on behalf of beneficiaries who were also covered by private insurance companies administered by Caremark… [ Read More ]
Accusations of insularity and interference haunt the Teva board by Andrew Jack Published on ft.com
Even by the standards of the regular leaks of sensitive corporate material from Teva, images on Israeli television last October showed a letter from senior management to its directors was still explosive… [ Read More ]Justice Department Announces $3.8 Billion In False Claims Act Recoveries In FY 2013 by Lauren Slive Published on jdsupra.com
On December 20, 2013, the Justice Department announced a total of $3.8 billion dollars in settlements and judgments from civil cases involving the False Claims Act for Fiscal Year (FY) 2013. Total recoveries under the False Claims Act since January 2009 have reached $17 billion… [ Read More ]
Live Industry News
Follow @ACI_Pharma and @ACI_Health
Join ACI Pharmaceuticals/Biotech/Life Sciences Experts Group
Join ACI Healthcare: Legal, Regulatory, and Compliance Experts Group
Related Events
For the complete list of all Pharma upcoming events: Click Here
For the complete list of all Healthcare upcoming events: Click Here
To download past Pharma conference materials: Click Here
To download past Healthcare conference materials: Click Here